AzTrials
AzTrials

Hernia, InguinalNCT01597011

Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation

An observational study of Hernia, Inguinal and Recurrence, run by Herlev Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In hernia repair a mesh is used to close the defect in the abdominal wall. This mesh is either secured with tissue penetrating devices (ex. staples,tacks or sutures) or fibrin glue (Tisseel/Tissucol) or left unfixated. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hernia, Inguinal, Recurrence, Chronic Pain
What is being tested?
Fibrin Sealant and Tissue-penetrating mesh-fixation
Type of treatment
Surgery or procedure
How many people
2,340 participants
Where
1 siteDenmark
Study dates
Jul 2012to Sep 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients will be enrolled based on their registration in the Danish Hernia Database. All patients in the database who have undergone laparoscopic inguinal hernia repair from January 2009 to September 2012 will be included.

Who may be able to join

  • inguinal hernia repair from January 2009-September 2012

Who cannot join

  • Patients lost to follow-up

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Herlev Hospital

    Herlev, 2730

Other trials in Denmark

About this study

In hernia repair a mesh is used to close the defect in the abdominal wall. This mesh is either secured with tissue penetrating devices (ex. staples,tacks or sutures) or fibrin glue (Tisseel/Tissucol) or left unfixated.

The investigators believe, and previous studies indicate, that the use of fibrin glue greatly reduces the amount of postoperative complications (ex. chronic pain, impaired ejaculation in men or recurrence of the hernia)when compared with the use of tacks or staples.

The aim of this study is to compare the recurrence rates and amount of postoperative complications in patients who have had inguinal hernia repair with fibrin glue and in patients who have had inguinal hernia repair with tacks, staples or sutures.

Read the detailed description

The study will use prospectively collected data from the Danish Hernia Database to find the patients. The patients will be contacted using a questionnaire.

Being tested
Fibrin Sealant, Tissue-penetrating mesh-fixation
Keywords
Hernia, Inguinal, Hernia repair, Fibrin Tissue Adhesive, Tisseel, Tissucol, Recurrence, Chronic Pain, Dysejaculation
Medical subject headings
Hernia, Inguinal, Recurrence, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fibrin SealantProcedure or surgery

    Also called Tisseel, Fibrin glue

    Use of fibrin sealant for mesh fixation in laparoscopic inguinal hernia repair,

  • Tissue-penetrating mesh-fixationProcedure or surgery

    Also called Protacks, Hernia stapler

    Use of tacks, staples or sutures for mesh fixation in inguinal hernia repair

Study groups in NCT01597011
Study groupRoleWhat they receive
Fibrin sealant groupPatients who have undergone laparoscopic inguinal hernia repair with fibrin sealant for mesh fixation
Receives: Procedure: Fibrin Sealant
Tissue-penetrating fixation groupPatients who have undergone laparoscopic inguinal hernia repair with the use of tacks, staples or sutures for mesh fixation
Receives: Procedure: Tissue-penetrating mesh-fixation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chronic pain

    Reported pain (questionnaire) from one year after procedure

    Measured: within period from one year after procedure until follow-up

Secondary outcomes (2)
  1. Recurrence

    Reherniation at repaired site. Defined as a clinically observable hernia or reoperation prior to follow-up

    Measured: within period from procedure to follow-up

  2. dysejaculation

    Reported ejaculatory dysfunction in male patients

    Measured: Debut within period from procedure to follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2012 (estimated)
  2. Study startJul 2012
  3. Primary completionSep 2014
  4. Study completionSep 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
2,340 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01597011
Sponsor's protocol ID
BS12-000733
Status last verified
Mar 2015
First submitted
9 May 2012
Last updated
18 Mar 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hernia, Inguinal and Recurrence, run by Herlev Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chronic pain (time frame: within period from one year after procedure until follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in